trending Market Intelligence /marketintelligence/en/news-insights/trending/qVo5gDO14WI5L7K7VdckVg2 content esgSubNav
In This List

Reata Pharmaceuticals withdraws $86.3M stock offering

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints


Reata Pharmaceuticals withdraws $86.3M stock offering

Reata Pharmaceuticals Inc. is withdrawing a registration statement for the sale of up to $86.3 million worth of class A common shares.

The shelf registration was filed earlier this month and is being withdrawn due to "unfavorable market conditions."